Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**parodur Liquid** is a ready-to-use, alcohol-free topical dental mouth-rinse product from lege artis Pharma for daily oral prophylaxis. It is marketed to reduce bacterial dental plaque and help prevent gingivitis, periodontitis, peri-implantitis, and dental caries. Public product information identifies chlorhexidine, fluoride, and xylitol among its functional ingredients; chlorhexidine provides broad antiseptic plaque reduction, while fluoride and xylitol support caries prevention. It is supplied as a 200 mL mouth-rinse solution for use after toothbrushing. ([medipreis.de](https://www.medipreis.de/produktdownloads/packungsbeilagen/parodur-liquid-mundspuelloesung-200-ml-lege-artis-pharma-gmbh-co-kg-09735499.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on parodur Liquid.